Latest Administration News

Queste Communications reported a strong cash inflow from investing activities in April 2025, driven by a $3 million receipt linked to the termination of an iron-ore royalty. The company ended the month with a robust cash position of over $4.1 million.

Genetic Technologies Limited has officially exited external administration following the effectuation of a Deed of Company Arrangement, marking a significant shift in its corporate governance and creditor relations.

The Takeovers Panel has received a contentious application from Keybridge Capital challenging Yowie Group’s recent private share placement, alleging breaches of takeover laws amid internal disputes within Keybridge.

EBR Systems has won FDA approval for its pioneering leadless WiSE CRT System, setting the stage for a phased US commercial rollout. The company also secured key Medicare reimbursement pathways and expanded manufacturing capacity, though financial sustainability remains a concern.

Anteris Technologies has submitted its FDA Investigational Device Exemption for the pivotal PARADIGM Trial of its DurAVR heart valve and marked a milestone of 100 patients treated, while expanding manufacturing capacity amid rising R&D costs.

5E Advanced Materials has raised $6.35 million through a private placement to advance its boron and lithium project in Southern California, aiming to strengthen U.S. supply chains and move closer to commercialization.

News Corporation has updated its financial statements to reflect the sale of Foxtel, reporting a 3% revenue increase in fiscal 2024 driven by its Digital Real Estate Services and Book Publishing segments, alongside a 66% rise in net income from continuing operations.

Sarama Resources Ltd reported a $673,644 net loss for Q1 2025, reflecting ongoing exploration costs and capital raises, while navigating arbitration funding with Burkina Faso authorities.

US Masters Residential Property Group reported solid Q1 2025 sales of US$48.07 million and a 5% rise in net operating income, while reducing senior debt by over US$31 million despite ongoing market volatility.

Highfield Resources has obtained a standby loan facility from EMR Capital to support its operations and strategic transaction progress, including advancing its flagship Muga Project. The company also extended the maturity of its convertible loan notes, underscoring ongoing investor confidence during a pivotal phase.

Neuren Pharmaceuticals has received official FDA minutes confirming the primary endpoints for its pivotal Phase 3 trial of NNZ-2591 targeting Phelan-McDermid syndrome, reinforcing the positive signals from earlier studies.

Life360, Inc. reported a strong Q1 2025 with 32% revenue growth to $103.6 million, driven by a 33% increase in subscription revenue and a return to profitability with $4.4 million net income. The company also advanced its strategic positioning through a $4.5 million acquisition and a key partnership.